Achim Rosemann

533 total citations
32 papers, 324 citations indexed

About

Achim Rosemann is a scholar working on Physiology, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Achim Rosemann has authored 32 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Physiology, 16 papers in Molecular Biology and 13 papers in Reproductive Medicine. Recurrent topics in Achim Rosemann's work include Biomedical Ethics and Regulation (23 papers), Pluripotent Stem Cells Research (14 papers) and Science, Research, and Medicine (11 papers). Achim Rosemann is often cited by papers focused on Biomedical Ethics and Regulation (23 papers), Pluripotent Stem Cells Research (14 papers) and Science, Research, and Medicine (11 papers). Achim Rosemann collaborates with scholars based in United Kingdom, China and Sweden. Achim Rosemann's co-authors include Margaret Sleeboom‐Faulkner, Xinqing Zhang, Susan Molyneux‐Hodgson, Li Jiang, Michele Farisco, Inga Ulnicane, Arleen Salles, Bernd Carsten Stahl, George Ogoh and Sven Nyholm and has published in prestigious journals such as SHILAP Revista de lepidopterología, Social Science & Medicine and Trends in biotechnology.

In The Last Decade

Achim Rosemann

29 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Achim Rosemann United Kingdom 11 145 125 62 60 39 32 324
Sonia M. Suter United States 14 115 0.8× 139 1.1× 82 1.3× 130 2.2× 31 0.8× 31 496
Christine Hauskeller United Kingdom 15 124 0.9× 146 1.2× 33 0.5× 112 1.9× 40 1.0× 32 486
Esther van Zimmeren Belgium 9 132 0.9× 110 0.9× 34 0.5× 83 1.4× 16 0.4× 32 367
Christopher Thomas Scott United States 16 304 2.1× 418 3.3× 73 1.2× 177 3.0× 72 1.8× 56 767
Niki Vermeulen United Kingdom 13 59 0.4× 97 0.8× 24 0.4× 51 0.8× 22 0.6× 33 540
Bruce Sun United States 10 65 0.4× 253 2.0× 11 0.2× 42 0.7× 13 0.3× 19 543
Radhika Rao United States 9 37 0.3× 89 0.7× 43 0.7× 59 1.0× 10 0.3× 19 201
Sharon Durfy United States 15 24 0.2× 250 2.0× 23 0.4× 125 2.1× 13 0.3× 40 878
Patrick F. Terry United States 10 61 0.4× 140 1.1× 5 0.1× 108 1.8× 9 0.2× 14 547
Charlott Sellberg Sweden 15 69 0.5× 207 1.7× 52 0.8× 31 0.5× 5 0.1× 41 813

Countries citing papers authored by Achim Rosemann

Since Specialization
Citations

This map shows the geographic impact of Achim Rosemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Achim Rosemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Achim Rosemann more than expected).

Fields of papers citing papers by Achim Rosemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Achim Rosemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Achim Rosemann. The network helps show where Achim Rosemann may publish in the future.

Co-authorship network of co-authors of Achim Rosemann

This figure shows the co-authorship network connecting the top 25 collaborators of Achim Rosemann. A scholar is included among the top collaborators of Achim Rosemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Achim Rosemann. Achim Rosemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farisco, Michele, Giuliano Di Baldassarre, Emilio Cartoni, et al.. (2024). A method for the ethical analysis of brain-inspired AI. Artificial Intelligence Review. 57(6). 4 indexed citations
2.
Rosemann, Achim & Susan Molyneux‐Hodgson. (2023). Challenge-driven innovation and responsible innovation: dynamics and disconnects explored through the UK’s industrial biotechnology sector. Journal of Responsible Innovation. 10(1). 3 indexed citations
3.
Ogoh, George, Simisola Akintoye, Damian Eke, et al.. (2023). Developing capabilities for responsible research and innovation (RRI). SHILAP Revista de lepidopterología. 15. 100065–100065. 3 indexed citations
4.
Stahl, Bernd Carsten, Simisola Akintoye, Berit Bringedal, et al.. (2021). From Responsible Research and Innovation to responsibility by design. Journal of Responsible Innovation. 8(2). 175–198. 48 indexed citations
5.
Evers, Kathinka, Michele Farisco, Nikolas Rose, et al.. (2021). Opinion on Trust and Transparency in Artificial Intelligence - Ethics&Society, The Human Brain Project. Zenodo (CERN European Organization for Nuclear Research). 5 indexed citations
6.
Rosemann, Achim, Brigitte Nerlich, Christine Hauskeller, et al.. (2019). Heritable Genome Editing in a Global Context: National and International Policy Challenges. The Hastings Center Report. 49(3). 30–42. 15 indexed citations
7.
Rosemann, Achim, et al.. (2019). Shaping stem cell therapies in Argentina: regulation, risk management and innovation policies. SHILAP Revista de lepidopterología. 21(50). 116–155. 5 indexed citations
8.
Rosemann, Achim, et al.. (2018). Attitudes Towards the Donation of Human Embryos for Stem Cell Research Among Chinese IVF Patients and Students. Journal of Bioethical Inquiry. 15(3). 441–457. 7 indexed citations
9.
Jiang, Li & Achim Rosemann. (2018). Human Embryo Gene Editing in China: The Uncertain Legal Status of the Embryo. BioSocieties. 14(1). 46–66. 7 indexed citations
10.
Sleeboom‐Faulkner, Margaret, et al.. (2018). Regulatory capacity building and the governance of clinical stem cell research in China. Science and Public Policy. 45(3). 431–431.
11.
Rosemann, Achim, et al.. (2017). Influence of light condition on medication care in a hospital. TU/e Research Portal. 202–206. 2 indexed citations
12.
Rosemann, Achim, et al.. (2017). Special Focus Issue on Regenerative Medicine in Society: Interdisciplinary Perspectives (Part I) – Foreword. Regenerative Medicine. 12(6). 577–580. 2 indexed citations
13.
Rosemann, Achim, Li Jiang, & Xinqing Zhang. (2017). Human Germ Line Gene Editing: Why Comparative, Cross-National Studies of Public Viewpoints are Important?. Sussex Research Online (University of Sussex). 5(1). 1 indexed citations
14.
Rosemann, Achim, et al.. (2017). Special Focus Issue on Regenerative Medicine in Society: Interdisciplinary Perspectives (Part II) – Foreword. Regenerative Medicine. 12(7). 733–736. 2 indexed citations
15.
Sleeboom‐Faulkner, Margaret, et al.. (2017). Regulatory capacity building and the governance of clinical stem cell research in China. Science and Public Policy. 45(3). 416–427. 5 indexed citations
16.
Sleeboom‐Faulkner, Margaret, Alex Faulkner, Achim Rosemann, et al.. (2016). Comparing national home-keeping and the regulation of translational stem cell applications: An international perspective. Social Science & Medicine. 153. 240–249. 27 indexed citations
17.
Rosemann, Achim, et al.. (2015). The pluralization of the international: Resistance and alter-standardization in regenerative stem cell medicine. Social Studies of Science. 46(1). 112–139. 19 indexed citations
18.
Rosemann, Achim. (2015). Stem Cell Treatments for Neurodegenerative Diseases: Challenges from a science, Business and Healthcare Perspective. Neurodegenerative Disease Management. 5(2). 85–87. 8 indexed citations
19.
20.
Hotfilder, Marc, Achim Rosemann, Claudia Langebrake, et al.. (2006). Lack of expression of the chondroitin sulphate proteoglycan neuron‐glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11). British Journal of Haematology. 133(3). 337–344. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sonia M. Suter Breakdown of academic impact, for papers by Christine Hauskeller Breakdown of academic impact, for papers by Esther van Zimmeren Breakdown of academic impact, for papers by Christopher Thomas Scott Breakdown of academic impact, for papers by Niki Vermeulen Breakdown of academic impact, for papers by Bruce Sun Breakdown of academic impact, for papers by Radhika Rao Breakdown of academic impact, for papers by Sharon Durfy Breakdown of academic impact, for papers by Patrick F. Terry Breakdown of academic impact, for papers by Charlott Sellberg
Rankless by CCL
2026